目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL PLATELET RICH PLASMA MARKET, BY TYPE
6.1. Overview
6.2. Pure
6.3. Leucocyte rich
6.4. Others

7. GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION
7.1. Overview
7.2. Orthopedics
7.3. Sports Medicine
7.4. Cosmetic Surgery
7.5. Dermatology
7.6. Ophthalmic Surgery
7.7. Neurosurgery
7.8. General Surgery
7.9. Others

8. GLOBAL PLATELET RICH PLASMA MARKET, BY END-USE
8.1. Overview
8.2. Hospitals
8.3. Clinics
8.4. Others

9. GLOBAL PLATELET RICH PLASMA MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Platelet Rich Plasma Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Platelet Rich Plasma Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES
11.1. Arthrex, Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. DePuy Synthes
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Zimmer Biomet Holdings, Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Terumo Corporation
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Stryker Corporation
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. EmCyte Corporation
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Cesca Therapeutics Inc.
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Regen Lab SA
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Dr. PRP America LLC
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. AdiStem Ltd.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL PLATELET RICH PLASMA MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL PLATELET RICH PLASMA MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 9 US: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 US: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 US: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 12 CANADA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 CANADA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 10 ITALY: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 11 ITALY: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 ITALY: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 16 UK: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 17 UK: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 UK: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 28 CHINA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 29 CHINA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 30 CHINA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 31 INDIA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 INDIA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 INDIA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: PLATELET RICH PLASMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: PLATELET RICH PLASMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: PLATELET RICH PLASMA MARKET, BY END-USE, 2018-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PLATELET RICH PLASMA MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PLATELET RICH PLASMA MARKET
FIGURE 4 GLOBAL PLATELET RICH PLASMA MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL PLATELET RICH PLASMA MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL PLATELET RICH PLASMA MARKET, SHARE (%), BY END-USE, 2022
FIGURE 7 GLOBAL PLATELET RICH PLASMA MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: PLATELET RICH PLASMA MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: PLATELET RICH PLASMA MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: PLATELET RICH PLASMA MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: PLATELET RICH PLASMA MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL PLATELET RICH PLASMA MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 ARTHREX, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ARTHREX, INC.: SWOT ANALYSIS
FIGURE 15 DEPUY SYNTHES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 DEPUY SYNTHES: SWOT ANALYSIS
FIGURE 17 ZIMMER BIOMET HOLDINGS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 ZIMMER BIOMET HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 19 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 TERUMO CORPORATION: SWOT ANALYSIS
FIGURE 21 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 STRYKER CORPORATION: SWOT ANALYSIS
FIGURE 23 EMCYTE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 EMCYTE CORPORATION: SWOT ANALYSIS
FIGURE 25 CESCA THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 CESCA THERAPEUTICS INC.: SWOT ANALYSIS
FIGURE 27 REGEN LAB SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 REGEN LAB SA: SWOT ANALYSIS
FIGURE 29 DR. PRP AMERICA LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 DR. PRP AMERICA LLC: SWOT ANALYSIS
FIGURE 31 ADISTEM LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ADISTEM LTD.: SWOT ANALYSIS